Search Results - "Sinnett, Mark J."

Assessment of Patiromer Monotherapy for Hyperkalemia in an Acute Care Setting by Di Palo, Katherine E, Sinnett, Mark J, Goriacko, Pavel

“…Hyperkalemia is a common electrolyte disorder in hospitalized patients; however, the clinical usefulness of administering patiromer for reduction of serum…”
Get full text

ASHP Guidelines on Medication-Use Evaluation by Afanasjeva, Janna, Burk, Muriel, Cunningham, Francesca (Fran), Fanikos, John, Gabay, Michael, Hayes, Genevieve (Jeni), Masters, Patricia L, Rodriguez, Ryan, Sinnett, Mark J

Get full text

Evaluating Pharmacist-Led Heart Failure Transitions of Care Clinic: Impact of Analytic Approach on Readmission Rate Endpoints by Cheng-Lai, Angela, Prlesi, Lendita, Murthy, Sandhya, Bellin, Eran Y., Sinnett, Mark J., Goriacko, Pavel

“…Studies evaluating pharmacist-led transitions of care (TOC) services for heart failure patients reported profound decreases in hospital readmissions. Most…”
Get full text

You Have the Tools . . . . Now Create That PPMI Model by Sinnett, Mark J.

Get full text

Progress and Transition: So How Are We Doing? by Sinnett, Mark J.

Get full text

President’s Message: Be the Change by Sinnett, Mark J.

Get full text

Ordering Interruptions in a Tertiary Care Center: A Prospective Observational Study by Dadlez, Nina M, Azzarone, Gabriella, Sinnett, Mark J, Resnick, Micah, Ushay, H Michael, Adelman, Jason S, Broder, Molly, Duh-Leong, Carol, Huang, Joyce, Kiely, Victoria, Nadler, Ariella, Nelson, Vayola, Simcik, Jared, Rinke, Michael L

“…By self-report, interruptions may contribute to up to 80% of ordering errors. A greater understanding of the frequency and context of interruptions during…”
Get more information

Improving hospital venous thromboembolism prophylaxis with electronic decision support by Bhalla, Rohit, Berger, Matthew A., Reissman, Stan H., Yongue, Brandon G., Adelman, Jason S., Jacobs, Laurie G., Billett, Henny, Sinnett, Mark J., Kalkut, Gary

“…BACKGROUND Venous thromboembolism (VTE) disease prophylaxis rates among medical inpatients have been noted to be <50%. OBJECTIVE Our objective was to evaluate…”
Get full text

Peak Antifactor Xa Activity Produced by Dalteparin Treatment in Patients with Renal Impairment Compared with Controls by Shprecher, Adam R., Cheng-Lai, Angela, Madsen, Eileen M., Cohen, Hillel W., Sinnett, Mark J., Wong, Serena T., Billett, Henny H.

“…Study Objective. To evaluate the relationship between impaired renal function and antifactor Xa activity in patients receiving dalteparin. Design. Open‐label…”
Get full text

Three Characteristics to Success

Get full text

We Can’t Deny It: We Are Leaders by Sinnett, Mark J

Get full text

Why Should You Be a Member, You Ask? (Hint: It isn’t Always About the CE) by Sinnett, Mark J

Get full text

High-Dose Intramuscular Triamcinolone in Severe, Chronic, Life-Threatening Asthma by Ogirala, Raja G, Aldrich, Thomas K, Prezant, David J, Sinnett, Mark J, Enden, Jay B, Williams, M. Henry

“…THE majority of patients with asthma have mild symptoms that can be controlled with beta-2 agonists, cromolyn, theophylline, inhaled corticosteroids, or a…”
Get full text

Case Study: Challenges, Successes and Lessons Learned from Implementing Computerized Physician Order Entry (CPOE) at Two Distinct Health Systems: Implications of CPOE on the Pharmacy and the Medication-Use Process by Manzo, John, Sinnett, Mark J., Sosnowski, Frank, Begliomini, Robert, Green, Jill, Pane, Fred

“…The purpose of this case study is to provide an understanding of the divergent experiences, challenges, and successes associated with implementing Computerized…”
Get full text

Impact of Monitoring Vancomycin Peak and Trough Concentrations versus Trough Concentrations Alone on Dose Adjustments: An Outcomes Analysis by Benkert, Steven C, Sinnett, Mark J, Amodio-Groton, Maria

Get full text